Yiannis Kiachopoulos

Anna Tzani

Danai Mavreli

Rachael Burroughs

Noelle Baquiche

Angeliki Andrianopoulou

Magdalena Sommenvik

Artur Saudabayev

Causaly, a leader in R&D Analytics that allows researchers and specialists to
intuitively map and navigate the intricate landscape of...

Alex Meissner joins Causaly as VP Strategy & Business Operations

Causaly, the London-based company that allows researchers and specialists to intuitively map and navigate the intricate landscape of biomedical research, has raised $17 million from investors to grow its team and expand into new markets.

Causaly raises $17 million to accelerate biomedical research and discovery of scientific breakthroughs

At Causaly we're excited to announce a new partnership with University College
London (UCL) to help accelerate research into the...

Covid-19: Causaly partners with UCL to accelerate coronavirus research

Causaly uses artificial intelligence to rapidly read, understand and interpret vast databases of biomedical knowledge.

At Causaly, we're honored to be supporting the 2019-nCoV Collective Research Initiative led by the Global Health Drug Discovery Institute in Beijing (GHDDI).

Causaly provides Covid-19 dataset to Bill and Melinda Gates' funded Global Health Drug Discovery Institute

We're delighted to have been named in the Top 10 Greek founded companies to watch in 2020 by EU Startups. The list was compiled according to growth rate, team numbers, funding closed, sector and more.

Causaly named in Top 10 Greece founded companies to watch in 2020

London, November 19 – Causaly, the AI company that is teaching computers to
read, understand and interpret all biomedical knowledge ever...

Causaly raises $5m in Series A round led by Pentech Ventures

Causaly Inc., an AI for Biomedical cause & effect discovery, announces today the completion of a $1m seed round led by Marathon Venture Capital.

Featured article

Alex Meissner joins Causaly as VP Strategy & Business Operations

Posts listed under News

Sign up for Causaly newsletter